Webcast
Ensuring Sponsor and Site ROI from Portal Implementation
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
The return on investment from using a clinical trial portal to manage document exchange and communication with investigative sites versus using traditional paper-based methods is clear. From reducing study start-up cycle time to expediting document distribution and management during conduct and close-out, the time and money savings are measurable. In addition, there are added benefits of security and control that come with using a portal that contribute to ROI. However, most of the time, clinical trial portal ROI models are built only from the sponsor perspective, leaving investigative sites questioning, “What’s in it for me? This is just one more system I have to deal with!” To effectively implement a clinical trial portal, investigator site acceptance, adoption and use is critical. To get investigative sites on board, sponsors need to demonstrate how a portal is going to save them time and make their clinical trial participation easier, not harder. In addition to reviewing the sponsor ROI model, this session provides a practical overview of clinical trial portal requirements necessary to ensure site adoption and demonstrate ROI to sites.
- The importance of site acceptance, adoption and use of a portal
- Conveying the value of a portal to sites
- ROI from use of a portal for both sponsors and sites
More Webcasts
Whistleblowing, Bounty Hunting, and Retaliation: New Compliance Challenges for your Organization
This webcast will provide in house counsel, compliance professionals, and HR with an overview of:
- The latest whistleblower protection laws, including heightened FCPA enforcement and how the Dodd-Frank corporate whistleblower program is turning employees into bounty hunters.
- Anti-retaliation protections, including recent cases that have changed both the breadth and scope of retaliation claims.
- Practical strategies and best practices for organizations to mitigate skyrocketing whistleblower and retaliation risk.
On-Demand Video Webcast: Intellectual Property M&A
mergermarket, in association with IntraLinks, hosted the live webcast, Intellectual Property M&A. The webcast will discuss some the importance of Intellectual Property as a driver of M&A.
Podcast: Quarterly M&A Update
In this latest quarterly podcast, mergermarket and IntraLinks assembled a panel of transatlantic dealmakers to discuss what influenced M&A from April to September. After a bumper first half for global deal volumes, Q3 saw the market hit by a wave of uncertainty over sovereign debt and sluggish global economic growth. But what was our panel’s impression of the market?
IntraLinks for Alternative Investment Fund Administrators: Collaborating to Increase the Top and Bottom Lines
Discover how IntraLinks can help Fund Administrators capitalize on emerging opportunities while controlling their costs. The presentation will walk you through the IntraLinks solutions and capabilities Fund Administrators are leveraging to expand their service suite, engage earlier with prospects and attract large self administered funds that are moving to 3rd party administration.
Strengthening Sponsor/CRO and Clinical Research Site Connections
Understand how the use of extended enterprise collaboration technologies is helping the clinical research community gain operational efficiencies and strengthen relationships between clinical research sites and Sponsors/CROs. Hear firsthand how clinical research sites interact, correspond, collaborate and share information with Sponsor Organizations, and their perceived challenges with their current methods.